4-(acetylamino)benzoic acid-1-(dimethylamino)-2-propanol CAS:61990-51-0

This compound demonstrates diverse applications in the pharmaceutical industry: Analgesics: It is explored for its potential as an analgesic agent, contributing to the development of pain relief medications with improved efficacy and reduced side effects. Local Anesthetics: Researchers investigate its use as a local anesthetic for topical and regional anesthesia, providing temporary numbing effects for medical procedures and surgeries. Anti-inflammatory Drugs: It may serve as a precursor or active ingredient in the synthesis of anti-inflammatory drugs used to treat conditions such as arthritis and inflammatory disorders. Antipyretics: This compound is studied for its antipyretic properties, potentially helping to reduce fever and alleviate associated symptoms in various infectious and inflammatory conditions. Central Nervous System Drugs: It is examined for its effects on the central nervous system, including potential applications in neuropharmacology for the treatment of neurological disorders. Pharmacokinetics Studies: Researchers utilize it in pharmacokinetics studies to investigate drug absorption, distribution, metabolism, and excretion profiles, providing insights into its pharmacological properties. Drug Delivery Systems: It may be incorporated into drug delivery systems to enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes and patient compliance. Formulation Development: Pharmaceutical companies explore its compatibility with various excipients and formulation techniques to develop dosage forms such as tablets, capsules, and injections. Overall, 4-(Acetylamino)benzoic acid-1-(dimethylamino)-2-propanol holds promise as a versatile compound with potential applications in pain management, inflammation treatment, and central nervous system disorders, contributing to the advancement of pharmaceutical science and medicine.